Skip to content

National Healthcare NHC Other intangible assets—net

Other intangible assets—net at other companies

Acadia Healthcare logo
Acadia HealthcareACHC
$98.59M+25.1%
CHE
ChemedCHE
$80.42M-10.6%
Encompass Health Corporation logo
Encompass Health CorporationEHC
The Ensign Group logo
The Ensign GroupENSG
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Revenue$381.8M+2.2%
Net income$36.1M+11.8%

Balance sheet

See full
Cash & equivalents$85.5M-5.4%
Total debt$39.3M-80.6%
Total equity$1.1B+8.6%
Total assets$1.5B-1.6%

Cash flow

See full
Operating cash flow$62.5M+59.3%
CapEx$9.6M+57.1%
Free cash flow$52.9M+59.7%

Valuation

See full
Market cap$3.12B+73.0%
Enterprise value$3.07B+57.4%
P/E24.7×+8.0×
P/S+0.7×

Profitability

See full
Net margin8.3%+0.5pp
FCF margin11%+3.2pp

Returns & leverage

See full
Return on equity12.1%+0.9pp
Debt / equity-0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by National Healthcare in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: National Healthcare’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Healthcare's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is National Healthcare's other intangible assets—net?
National Healthcare (NHC) reported other intangible assets—net of $19.86M in Q1 2026.
How has National Healthcare's other intangible assets—net changed year-over-year?
National Healthcare's other intangible assets—net decreased by 0.0% year-over-year, from $19.86M to $19.86M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.